C. Ola Landgren, M.D., Ph.D. (IMAGE)

University of Miami Miller School of Medicine

C. Ola Landgren, M.D., Ph.D.

Caption

“If we are going to cure multiple myeloma, we need two things. One, we need really effective medicines. Second, we need to be able to make sure there is no disease left behind after these treatments,” said C. Ola Landgren, M.D., Ph.D., senior author of the study. “We are developing new and better technology designed to see where the disease is and make sure we are not missing it.”

Credit

Sylvester Comprehensive Cancer Center

Usage Restrictions

Use with attribution

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.